SynTheAll Pharmaceutical

WuXi AppTec, established in December 2000, is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing service company, with operating entities in both China and the United States. As a research-driven and customer-centric company, WuXi AppTec offers a comprehensive range of laboratory R&D and research production services to global pharmaceutical companies, biotechnology companies, and medical device companies, covering the entire process from drug discovery to market launch. WuXi AppTec's services aim to help global clients shorten drug and medical device R&D cycles and reduce R&D costs through cost-effective and efficient outsourcing services. Over the past decade, WuXi AppTec has successfully built a fully integrated R&D service technology platform. At its inception, WuXi AppTec achieved comprehensive development through its strong capabilities in discovery chemistry synthesis. In recent years, we have added a series of integrated services, including analytical services, bioanalytical services, process research, process development services, API production services, drug metabolism and pharmacokinetics services, research biology, pharmacology, formulations, toxicology, genomics services, biologics manufacturing services, production and sales of antibodies and biological diagnostic reagents, as well as clinical development and product registration services. Since its founding in December 2000, WuXi AppTec's employee count has grown from 4 to over 7,000, and its laboratories have expanded from a single one to a current R&D base and production facility of nearly 300,000 square meters. At the same time, WuXi AppTec continues to enhance its service capabilities and broaden its service areas to better meet the company's growing global business needs. As a leading pharmaceutical R&D outsourcing service company, WuXi AppTec will continue to provide high-quality pharmaceutical R&D services to global clients in both China and the United States, helping to develop more new drugs and products that benefit patients. Shanghai SynTheAll Pharmaceutical Co., Ltd., a wholly-owned subsidiary of WuXi AppTec, was established in December 2003 with a registered capital of 120 million RMB. It is an R&D-oriented production enterprise integrating process development and a cGMP-compliant production base for pharmaceutical intermediates and clinical APIs, primarily providing high-quality, high-technology content products and technical support to multinational pharmaceutical companies. In addition to its headquarters in Jinshan District, Shanghai, Shanghai SynTheAll Pharmaceutical Co., Ltd. also includes Shanghai SynTheAll Pharmaceutical R&D Co., Ltd. (Pudong New Area, Shanghai) and SynTheAll Pharmaceutical Changzhou Company (Changzhou, Jiangsu). Currently, the company has around 1,500 employees, including multiple managers with rich GMP production experience and technical R&D scientists, and possesses 57,000 square meters of GMP API and intermediate production facilities. It has passed ISO9001:2000 quality management certification and ISO14001 environmental management system certification, establishing a quality management system compliant with FDA cGMP standards. Leveraging WuXi AppTec's strong capabilities in organic chemistry synthesis and process R&D, along with advanced instrumentation and internationally standard laboratories and GMP facilities, SynTheAll Pharmaceutical helps WuXi AppTec achieve rapid transfer from R&D to industrial production, greatly shortening the R&D and production cycles for new products. Currently, SynTheAll Pharmaceutical enjoys a high reputation in providing R&D services to clients and has established long-term, stable, and mature strategic partnerships with most multinational pharmaceutical giants, including leading multinational pharmaceutical companies such as Merck, Pfizer, Eli Lilly, and GlaxoSmithKline. Since its establishment, Shanghai SynTheAll Pharmaceutical has placed great emphasis on technological innovation and R&D capability development. After years of technical accumulation, the company has achieved multiple scientific and technological achievements and has been rated as a Shanghai High-Tech Enterprise. In addition, SynTheAll Pharmaceutical has also received a series of other honors and titles from the government, including Shanghai Enterprise Technology Center and Top 50 Industrial and Commercial Enterprises in Jinshan District. The company is currently developing rapidly and needs to recruit more outstanding talents from society to strengthen our team and create a bright future together with the company. We sincerely invite you to join us! :*